Open access · US-GOV via ClinicalTrials.gov Clinical trial

Sarcopenia in Cirrhosis and Chronic Inflammatory Bowel Disease: An Austrian Biobanking Study

Authors not listed

Medical University of Graz · 2023

Chronic inflammation Telomerase activation Human Randomized controlled trial

Abstract

The investigators aim to set up a biobanking study in Graz, Austria, to study sarcopenia in liver cirrhosis and chronic inflammatory bowel disease by collecting a standardized dataset including routine clinical and biochemical tests; biosamples to assess novel biomarker as well as advanced clinical assessments. In a small country like Austria, a nationwide biobanking study can enhance research enormously. The investigators therefore aim to extend the registry to all tertiary liver care centers in Austria in a second step.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-18 MST

Cite this

APA

Anonymous. (2023). Sarcopenia in Cirrhosis and Chronic Inflammatory Bowel Disease: An Austrian Biobanking Study. <em>Medical University of Graz</em>. https://clinicaltrials.gov/study/NCT06632743

Vancouver

Anonymous. Sarcopenia in Cirrhosis and Chronic Inflammatory Bowel Disease: An Austrian Biobanking Study. Medical University of Graz. 2023.

BibTeX

@misc{anon2023Sarcop, title = {Sarcopenia in Cirrhosis and Chronic Inflammatory Bowel Disease: An Austrian Biobanking Study}, author = {Anonymous}, journal = {Medical University of Graz}, year = {2023}, }